Novo Nordisk said on Wednesday it was aware of reports of 10 deaths and 100 hospitalisations of people who had taken compounded copies of its weight-loss and diabetes drugs. U.S. regulations allow ...
Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.
Lilly last week reported a rare $1.5 billion sales miss for its injectable obesity drug Zepbound and ... again be in focus when Novo reports results for its diabetes drug Ozempic and ...